nach oben

28.02.2024 | Neurology and Preclinical Neurological Studies - Original Article

Headache patterns in patent foramen ovale patients: beyond migraine with aura

verfasst von: Raluca Ștefania Badea, N. Grecu, A. C. Ribigan, F. Antochi, C. Tiu, B. O. Popescu

Erschienen in: Journal of Neural Transmission

Einloggen, um Zugang zu erhalten

Abstract

Patent foramen ovale (PFO) is a common cardiac anomaly linked with cryptogenic strokes and migraine, particularly migraine with aura. This study aims to explore the spectrum of headache disorders in PFO patients, focusing on identifying patterns beyond the well-established migraine-PFO connection. A retrospective observational study was conducted on patients diagnosed with PFO. Headache types were classified using the International Classification of Headache Disorders, 3rd edition. The study analyzed headache prevalence and patterns in PFO patients, comparing those with and without a history of stroke. Of 177 participants, 63 (35.59%) reported headaches. Tension-type headache was the most common (15.25%), followed by migraine without aura (11.30%) and migraine with aura (8.47%). Notably, migraine without aura was more prevalent than migraine with aura, contrasting previous assumptions. No significant differences were found in headache types based on stroke history. The study reveals a diverse spectrum of headache types in PFO patients, with migraine without aura being more common than migraine with aura. These findings suggest a need for broader diagnostic perspective and individualized treatment approaches in PFO patients with headaches.

Badea RS, Ribigan AC, Grecu N, Terecoasa E, Antochi FA, Mihaila B, Tiu S, C., Popescu BO (2023) Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events. Front Neurol 14:1104674. https://doi.org/10.3389/fneur.2023.1104674CrossRefPubMedPubMedCentral

Bayraktutan OF, Demir R, Ozel L, Ozdemir G, Ertekin A (2014) Prevalence of tension-type headache in individuals aged between 18–65 years in the Eastern Parts of Turkey. Eurasian J Med 46(2):78–83. https://doi.org/10.5152/eajm.2014.20CrossRefPubMedPubMedCentral

Benoliel R (2012) Trigeminal autonomic cephalgias. Br J Pain 6(3):106–123. https://doi.org/10.1177/2049463712456355CrossRefPubMedPubMedCentral

Buonacera A, Stancanelli B, Malatino L (2019) Stroke and hypertension: an Appraisal from Pathophysiology to Clinical Practice. Curr Vasc Pharmacol 17(1):72–84. https://doi.org/10.2174/1570161115666171116151051CrossRefPubMed

Calviere L, Tall P, Massabuau P, Bonneville F, Larrue V (2013) Migraine with aura and silent brain infarcts lack of mediation of patent foramen ovale. Eur J Neurol 20(12):1560–1565. https://doi.org/10.1111/ene.12240CrossRefPubMed

Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP (2006) Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26(8):934–939. https://doi.org/10.1111/j.1468-2982.2006.01156.xCrossRefPubMed

Collaborators GBDH (2018) Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17(11):954–976. https://doi.org/10.1016/S1474-4422(18)30322-3CrossRef

Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A (2005) Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 6(4):328–330. https://doi.org/10.1007/s10194-005-0223-9CrossRefPubMedPubMedCentral

Dao CN, Tobis JM (2011) PFO and paradoxical embolism producing events other than stroke. Catheter Cardiovasc Interv 77(6):903–909. https://doi.org/10.1002/ccd.22884CrossRefPubMed

Faggiano P, Frattini S, Piovesana P, Lorusso R, Chiari E, Scolari F, Padovani A, Cas LD (2012) Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. Int J Cardiol 156(1):47–52. https://doi.org/10.1016/j.ijcard.2010.10.032CrossRefPubMed

Ferrante T, Manzoni GC, Russo M, Camarda C, Taga A, Veronesi L, Pasquarella C, Sansebastiano G, Torelli P (2013) Prevalence of tension-type headache in adult general population: the PACE study and review of the literature. Neurol Sci 34(Suppl 1):S137–138. https://doi.org/10.1007/s10072-013-1370-4CrossRefPubMed

Ferrarini G, Malferrari G, Zucco R, Gaddi O, Norina M, Pini LA (2005) High prevalence of patent foramen ovale in migraine with aura. J Headache Pain 6(2):71–76. https://doi.org/10.1007/s10194-005-0154-5CrossRefPubMedPubMedCentral

Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L (2010) Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation 121(12):1406–1412. https://doi.org/10.1161/CIRCULATIONAHA.109.895110CrossRefPubMed

Kimmelstiel C, Gange C, Thaler D (2007) Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv 69(5):740–746. https://doi.org/10.1002/ccd.21025CrossRefPubMed

Kuper M, Rabe K, Holle D, Savidou I, Dommes P, Frings M, Diener HC, Katsarava Z (2013) Prevalence of cardiac right left shunts in migraine: a population-based case-control study. Neurol Sci 34(2):205–208. https://doi.org/10.1007/s10072-012-0986-0CrossRefPubMed

Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL (2002) Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atr Septal Aneurysm Stroke 33(3):706–711. https://doi.org/10.1161/hs0302.104543CrossRef

Lao AY, Sharma VK, Tsivgoulis G, Frey JL, Malkoff MD, Navarro JC, Alexandrov AV (2008) Detection of right-to-left shunts: comparison between the International Consensus and Spencer Logarithmic Scale criteria. J Neuroimaging 18(4):402–406. https://doi.org/10.1111/j.1552-6569.2007.00218.xCrossRefPubMed

Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002) Migraine in the United States: epidemiology and patterns of health care use. Neurology 58(6):885–894. https://doi.org/10.1212/wnl.58.6.885CrossRefPubMed

Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M, Mohsen A, Abuzaid A, Mansoor H, Mojadidi MK, Elgendy IY (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498. https://doi.org/10.1136/bmjopen-2017-020498CrossRefPubMedPubMedCentral

Moaref AR, Petramfar P, Aghasadeghi K, Zamirian M, Sharifkazemi MB, Rezaian S, Afifi S, Zare N, Rezaian GR (2009) Patent foramen ovale in patients with tension headache: is it as common as in migraineurs? An age- and sex-matched comparative study. J Headache Pain 10(6):431–434. https://doi.org/10.1007/s10194-009-0154-yCrossRefPubMedPubMedCentral

Nahas SJ, Young WB, Terry R, Kim A, Van Dell T, Guarino AJ, Silberstein SD (2010) Right-to-left shunt is common in chronic migraine. Cephalalgia 30(5):535–542. https://doi.org/10.1111/j.1468-2982.2009.02002.xCrossRefPubMed

Rundek T, Elkind MS, Tullio D, Carrera MR, Jin E, Sacco Z, R. L., Homma S (2008) Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 118(14):1419–1424. https://doi.org/10.1161/CIRCULATIONAHA.108.771303CrossRefPubMedPubMedCentral

Schwedt TJ, Demaerschalk BM, Dodick DW (2008) Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28(5):531–540. https://doi.org/10.1111/j.1468-2982.2008.01554.xCrossRefPubMed

Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19(2):109–117. https://doi.org/10.1038/s41582-022-00763-1CrossRefPubMed

Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23(1):34. https://doi.org/10.1186/s10194-022-01402-2CrossRefPubMedPubMedCentral

Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J (2002) Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 13(2):102–106. https://doi.org/10.1159/000047758CrossRefPubMed

Truong T, Slavin L, Kashani R, Higgins J, Puri A, Chowdhry M, Cheung P, Tanious A, Child JS, Perloff JK, Tobis JM (2008) Prevalence of migraine headaches in patients with congenital heart disease. Am J Cardiol 101(3):396–400. https://doi.org/10.1016/j.amjcard.2007.08.047CrossRefPubMed

Wei DY, Moreno-Ajona D, Renton T, Goadsby PJ (2019) Trigeminal autonomic cephalalgias presenting in a multidisciplinary tertiary orofacial pain clinic. J Headache Pain 20(1):69. https://doi.org/10.1186/s10194-019-1019-7CrossRefPubMedPubMedCentral

Titel: Headache patterns in patent foramen ovale patients: beyond migraine with aura
verfasst von: Raluca Ștefania Badea
N. Grecu
A. C. Ribigan
F. Antochi
C. Tiu
B. O. Popescu
Publikationsdatum: 28.02.2024
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-024-02760-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen